
On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners recommended to sell CVS Health Corp (NYSE:CVS). Terranova said he had bought the stock on January 20 at $101 and “it’s gone nowhere.”
Bryn Talkington of Requisite Capital Management named AbbVie Inc (NYSE:ABBV) for those looking for stocks outside energy and commodity. “It’s done great this year. It’s got a really nice dividend of over 3.4%. I think it gives good diversification with strong technicals and fundamentals,” she added.